WHO Traditional Medicine Strategy: 2002-2005
(2002; 70 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentAcknowledgements
Afficher le documentAcronyms, abbreviations and WHO Regions
Fermer ce répertoireKey points: WHO Traditional Medicine Strategy 2002 - 2005
Afficher le documentWhat is traditional medicine?
Afficher le documentWidespread and growing use
Afficher le documentWhy such broad use?
Afficher le documentUncritical enthusiasm versus uninformed scepticism
Afficher le documentChallenges in developing TM/CAM potential
Afficher le documentThe current role of WHO
Afficher le documentFramework for action
Afficher le documentStrategy implementation
Ouvrir ce répertoire et afficher son contenuChapter One: Global review
Ouvrir ce répertoire et afficher son contenuChapter Two: Challenges
Ouvrir ce répertoire et afficher son contenuChapter Three: The current role of WHO
Ouvrir ce répertoire et afficher son contenuChapter Four: International and national resources for traditional medicine
Ouvrir ce répertoire et afficher son contenuChapter Five: Strategy and plan of action 2002 - 2005
Afficher le documentAnnex One: List of WHO Collaborating Centres for Traditional Medicine
Ouvrir ce répertoire et afficher son contenuAnnex Two: Selected WHO publications and documents on traditional medicine
Afficher le documentReferences
Afficher le documentBack Cover

Framework for action

The WHO Traditional Medicines Strategy 2002 - 2005 reviews the status of TM/CAM globally, and outlines WHO's own role and activities in TM/CAM. But more importantly it provides a framework for action for WHO and its partners, aimed at enabling TM/CAM to play a far greater role in reducing excess mortality and morbidity, especially among impoverished populations. The strategy incorporates four objectives:

1. Policy - Integrate TM/CAM with national health care systems, as appropriate, by developing and implementing national TM/CAM policies and programmes.

2. Safety, efficacy and quality - Promote the safety, efficacy and quality of TM/CAM by expanding the knowledge-base on TM/CAM, and by providing guidance on regulatory and quality assurance standards.

3. Access - Increase the availability and affordability of TM/CAM, as appropriate, with an emphasis on access for poor populations.

4. Rational use - Promote therapeutically sound use of appropriate TM/CAM by providers and consumers.

Implementation of the strategy will initially focus on the first two objectives. Achieving the safety, efficacy and quality objective will provide the necessary foundation for achieving the access and rational use objectives.

vers la section précédente
vers la section suivante
Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 6 décembre 2017